Corticosteroid Therapy in COVID-19 Disease

被引:0
|
作者
Akbudak, Ismail Hakki [1 ]
机构
[1] Pamukkale Univ, Dept Internal Med, Div Intens Care Med, Fac Med, Denizli, Turkey
来源
关键词
Septic Shock; Coronavirus Infections; Respiratory Failure; Corticosteroids;
D O I
10.37678/dcybd.2020.2349
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Corticosteroid therapy has been used for many years and is still controversial in use. In the Coronovirus disease 2019 (COVID-19) outbreak, it is very important to find reliable treatment information for clinicians and patients. Low dose corticosteroids are also used in patients with septic shock, relative adrenal insufficiency and acute respiratory distress syndrome (ARDS). There is not enough evidence for its use in COVID-19. However, low dose use is recommended in the case of ARDS and septic shock in COVID-19 patients. Caution should be exercised until further evidence emerges surrounding the use of corticosteroids in COVID-19 patients.
引用
收藏
页码:30 / 31
页数:2
相关论文
共 50 条
  • [31] What can we learn about corticosteroid therapy as a treatment for COVID-19?
    J. Tang
    Osteoporosis International, 2020, 31 : 1595 - 1595
  • [32] A case of shock after 10 days systemic corticosteroid therapy for COVID-19
    Keiko Uemura
    Satoki Inoue
    Masahiko Kawaguchi
    JA Clinical Reports, 7
  • [33] Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study
    Li, Yiming
    Meng, Qinghe
    Rao, Xin
    Wang, Binbin
    Zhang, Xingguo
    Dong, Fang
    Yu, Tao
    Li, Zhongyi
    Feng, Huibin
    Zhang, Jinpeng
    Chen, Xiangyang
    Li, Hunian
    Cheng, Yi
    Hong, Xiaoyang
    Wang, Xiang
    Yin, Yimei
    Zhang, Zhongheng
    Wang, Dawei
    CRITICAL CARE, 2020, 24 (01)
  • [34] Ten reasons why corticosteroid therapy reduces mortality in severe COVID-19
    Anon, Jose M.
    Villar, Jesus
    INTENSIVE CARE MEDICINE, 2021, 47 (03) : 355 - 356
  • [35] Corticosteroid Injections and COVID-19 Infection Risk
    Miller, David C.
    Patel, Jaymin
    Gill, Jatinder
    Mattie, Ryan
    Saffarian, Mathew
    Schneider, Byron J.
    Popescu, Adrian
    Babaria, Vivek
    McCormick, Zachary L.
    PAIN MEDICINE, 2020, 21 (08) : 1703 - 1706
  • [36] Disease progression after discontinuation of corticosteroid treatment in a COVID-19 patient with ARDS
    Lam Nguyen-Ho
    Asian Pacific Journal of Tropical Medicine, 2022, (01) : 47 - 48
  • [37] Disease progression after discontinuation of corticosteroid treatment in a COVID-19 patient with ARDS
    Nguyen-Ho, Lam
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2022, 15 (01) : 47 - 48
  • [38] Blood glucose control and corticosteroid therapy in Covid-19 patients during the COVID-19 pandemic: Perspective from a district general hospital
    Roulston, G.
    Harding, J.
    Harper, R.
    McHenry, C.
    McKeever, E.
    McMullan, P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (SUPPL 4) : 126 - 127
  • [39] Antiviral therapy of coronavirus disease 2019 (COVID-19)
    Chen, Pao-Yu
    Wang, Jann-Tay
    Chang, Shan-Chwen
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2024, 123 : S47 - S54
  • [40] The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19
    Furci F.
    Caminati M.
    Senna G.
    Gangemi S.
    Clinical and Molecular Allergy, 19 (1)